homocysteine has been researched along with daunorubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bessede, G; Gambert, P; Lizard, G; Miguet, C; Neel, D | 1 |
Blom, HJ; Boers, GH; De Boo, TM; Haagsma, CJ; Laan, RF; Thomas, CM; van de Putte, LB; van Ede, AE | 1 |
1 trial(s) available for homocysteine and daunorubicin
Article | Year |
---|---|
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Daunorubicin; Female; Folic Acid; Genotype; Homocysteine; Humans; Leucovorin; Linear Models; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation | 2002 |
1 other study(ies) available for homocysteine and daunorubicin
Article | Year |
---|---|
Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Membrane Permeability; Cell Nucleus; Cells, Cultured; Copper; Cytarabine; Daunorubicin; Endothelium, Vascular; Etoposide; gamma-Glutamyltransferase; Homocysteine; Humans; Time Factors; Vinblastine | 2001 |